Revenue Management Complexity Costs Life Sciences Companies Billions
SAN MATEO, Calif. — May 12, 2020 – Model N, Inc., the leader in cloud revenue management solutions, today announced a webinar dedicated to the 2020 State of Revenue Report, highlighting key findings from Model N’s recent survey of C-level executives responsible for revenue management in the life sciences industry.
The 2020 State of Revenue Report details how revenue management challenges are having a serious impact on the business success of medical technology and pharmaceutical companies. Amid an increasingly demanding environment, almost all of the respondents (98%) report that optimizing and managing revenue is a challenge. And it has become dramatically more complicated in recent years, according to 82% of the executives surveyed. Poor controls over contract and regulatory compliance, discounts, and lack of visibility into revenue performance are among the issues cited.
Webinar attendees will receive a downloadable copy of the full 2020 State of Revenue Report and have the opportunity to participate in a live Q&A session with panelists. The webinar is scheduled for May 27 at 11 am PT/2 pm ET. Registration information can be found on Model N’s website.
State of Revenue for Life Sciences Webinar Highlights:
- Model N’s Life Sciences General Manager, Melonie Warfel and Model N’s Center of Excellence Vice President, Jesse Mendelsohn, will discuss preparing for regulatory change and uncertainty, controlling revenue leakage, leveraging digital transformation and technologies like AI, and managing global pricing in the cloud.
- Featured Guest Odalys Caprisecca of AstraZeneca: A pharmaceutical executive with over 25 years of experience, Odalys Caprisecca is Executive Director of Market Access at AstraZeneca. She is responsible for strategic pricing and trade and contract operations, as well as government pricing and operations, with a proven track record of designing and executing innovative solutions.
About Model N
Model N is a leading provider of cloud revenue management solutions for life sciences and high tech companies. Driving mission-critical business processes such as pricing, quoting, contracting, regulatory compliance, rebates, and incentives, our software helps companies know and grow their true top line and maximize every revenue moment at speed and scale. With deep industry expertise, Model N supports the complex business needs of the world’s leading brands in pharmaceutical, medical technology, semiconductor, and high-tech manufacturing across more than 120 countries, including Johnson & Johnson, AstraZeneca, Novartis, Microchip Technology, and ON Semiconductor. For more information, visit www.modeln.com.
Media Contact:
Laura Ruark
Bospar Public Relations
laura@bospar.com
